« PRIME OSSERVAZIONI CLINICHE ED EMATOLOGICHE SULL'IMPIEGO DELLA SARCOCLORINA NEL TRATTAMENTO DI ALCUNE EMOLINFOPATIE MALIGNE »
Open Access
- 1 November 1956
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 42 (6) , 931-937
- https://doi.org/10.1177/030089165604200609
Abstract
8 cases of Hodgkin's disease, 1 case of chronic myeloid leukemia and 1 case of reticulosarcoma have been treated with sarcochlorine (DL-para-bis (β-chloroethyl) aminophenylalanine). A marked cytostatic action of the compound, effectively influencing the general conditions, the febrile course and the zonal manifestations of the disease, was observed in all patients. Two negative aspects were demonstrated, i.e. a marked leukopenic influence of the cytostatic substance and a short duration of the clinical remissions.Keywords
This publication has 4 references indexed in Scilit:
- STUDIES ON THE ANTI-TUMOUR ACTIVITY OF p-DI-(2-CHLOROETHYL) AMINOPHENYLALANINE (SARCOLYSINE)The Lancet, 1955
- Studies on Cancerocidal Substances. XII. Reaction of N-Bis(^|^beta;-chloroethyl)amino Acids and their N-Oxides in an Aqueous SolutionPharmaceutical Bulletin, 1955
- N-Bis (^|^beta;-chloroethyl) amino Acids and their Effect upon the Yoshida Sarcoma.Pharmaceutical Bulletin, 1954
- Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalaninesJournal of the Chemical Society, 1954